Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132590) titled 'Neuropathic Ocular Pain Platform' on Sept. 16.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Eye Hospital, Wenzhou Medical University
Condition:
Neuropathic ocular pain,NOP
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-09-30
Target Sample Size: Neuropathic ocular pain cases:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=338209
Published by HT Digital Content Services with permission from Health Daily Digest....